Modulators of cystic fibrosis transmembrane conductance regulator
US12324802B2 · kind B2 · utility
0Cited by
205References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2021 |
| Grant date | Jun 10, 2025 |
| Priority date | — |
| Expiry date | Jul 11, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.